Access Pharmaceuticals Signs Agreement With Leading Biopharmaceutical Company to Develop CobOral Formulation of Widely-Marketed Injectable

Access Pharmaceuticals, Inc., a biopharmaceutical company leveraging its proprietary drug-delivery platforms to develop treatments in areas of oncology, cancer supportive care and diabetes, announced it has entered into a pre-licensing feasibility agreement with a leading biopharmaceutical company to develop an oral formulation of an undisclosed prostate cancer compound utilizing its proprietary vitamin B-12-based CobOral Drug Delivery Technology.

Lumerical Solutions’ FDTD Solutions 7.0 Delivers Optimization and Conformal Meshing to Photonic Design

Lumerical Solutions Inc., a global provider of nanophotonic design software, today unveiled innovative improvements to its flagship product FDTD Solutions 7.0. Improvements to FDTD Solutions 7.0 include an integrated parameter sweep and optimization environment, industry's first conformal mesh for nanophotonic design, an extended set of simulation primitives to facilitate the design of complex devices and support for Mac OS X.

For Personalized Medicine CPMC is the Gold Standard Study

Ok,

So I just wrapped up a meeting with some, well, nearly all of the most brilliant minds in Pharmacogenomics. Where was I? Yes, on the cover of USA Today's life section.....But where was I really?

Conference? No.

VC event? No.

I was at the Coriell Personalized Medicine Collaborative (CPMC) Pharmacogenomics Advisory Group meeting.

I am certain you all know about the CPMC now. But in case you have been sleeping.

Coriell is climbing the mountain, gaining collaborators, building camps. They are essentially doing all the hard work of study analysis so that you don't have to.

Brilliant if you ask me.

Who in the world has the time or money to cull data, looking for important findings?

Google funded "projects", Academic Programs and Not For Profits.

Who do you trust to give you unbiased reports?

NFPs.

Who is the NFP here? Coriell.

Why will CPMC win this battle? Even 23andSerge agree that CPMC is the gold standard

1. They have independent advisors and scientists

2. They have nearly all the best independent advisors and scientists

3. They have the support of the government, the community and oh yeah, the FDA isn't investigating them......

4. They have Mike Christman.

5. They have a team who believe in this moral imperative, not a pay check or stock options.

I vowed never to post what transpires at these meetings, but rest assured, it was truly academic heated debate with egos left at the door. This is precisely what you want when someone is going to tell you what your genetic material means for you.
The Sherpa Says: Coriell is on to something here. Something so valuable when the 1000 genomes and the rest of the genomes go public. Someone has to make sense of it all and study what it means......I am proud to be a part of it.

Election 2010 Predictions | Gene Expression

800px-SarahPalinElonFor Congress, I think that the breakdown will be:

Senate – 50 Republicans, 50 Democrats

House – 240 Republicans, 195 Democrats

My reasoning? I just took FiveThirtyEight’s numbers and shaded them a bit to the Republican side. There’s no point in making predictions unless you predict something novel and a bit off expectations. Additionally, since the readership here leans a little Left I am inclined to tweak you guys a bit and make the political Götterdämmerung even more terrifying, though I didn’t want to push my luck and give you an implausible value which you’d reject on the face of it.

Image Credit: Therealbs2002, Wikimedia Commons

Have ADMIXTURE run on your genetic data | Gene Expression

The last 24 hours of the initial sample collection phase of the Dodecad Ancestry Project are upon us. So if you have raw 23andMe data, you got a day to send it in, if you’re of the following groups:

-Greeks (not necessarily from Greece: Cypriots, Pontic Greeks from the former USSR, North Epirotes, Griko speakers from Italy, -Muslim rumca speakers from Turkey, etc. are all accepted)
-People from the Balkans
-People from Anatolia
-People from the Caucasus
-Italians
-Non-Indo-European speakers from Europe (e.g., Finns, Hungarians, Basques)
-Scandinavians and Icelanders
-Iranians
-Armenians
-Jews from Italy, the Balkans, or Anatolia
-Assyrians
-Arabs

The point of the project is to get a better picture of genetic variation in Eurasia, especially in undersampled groups.